Literature DB >> 26417575

Overcoming the hurdles of using PET/CT for target volume delineation in curative intent radiotherapy of non-small cell lung cancer.

Leila Tchelebi1, Hani Ashamalla1.   

Abstract

Entities:  

Year:  2015        PMID： 26417575      PMCID： PMC4560695          DOI： 10.3978/j.issn.2305-5839.2015.07.02

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  17 in total

Review 1.  PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer.

Authors:  Mia Schmidt-Hansen; David R Baldwin; Elise Hasler; Javier Zamora; Víctor Abraira; Marta Roqué I Figuls
Journal:  Cochrane Database Syst Rev       Date:  2014-11-13

Review 2.  Imaging techniques for tumour delineation and heterogeneity quantification of lung cancer: overview of current possibilities.

Authors:  Wouter van Elmpt; Catharina M L Zegers; Marco Das; Dirk De Ruysscher
Journal:  J Thorac Dis       Date:  2014-04       Impact factor: 2.895

3.  Radiotherapy planning: PET/CT scanner performances in the definition of gross tumour volume and clinical target volume.

Authors:  Ernesto Brianzoni; Gloria Rossi; Sergio Ancidei; Alfonso Berbellini; Francesca Capoccetti; Carla Cidda; Paola D'Avenia; Sara Fattori; Gian Carlo Montini; Gianluca Valentini; Alfredo Proietti; Carlo Algranati
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-08-26       Impact factor: 9.236

Review 4.  PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014.

Authors:  Tom Konert; Wouter Vogel; Michael P MacManus; Ursula Nestle; José Belderbos; Vincent Grégoire; Daniela Thorwarth; Elena Fidarova; Diana Paez; Arturo Chiti; Gerard G Hanna
Journal:  Radiother Oncol       Date:  2015-04-10       Impact factor: 6.280

5.  The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.

Authors:  Hani Ashamalla; Sameer Rafla; Kapila Parikh; Bahaa Mokhtar; Ganesh Goswami; Shravan Kambam; Hussain Abdel-Dayem; Adel Guirguis; Pamela Ross; Alex Evola
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-06-24       Impact factor: 7.038

6.  The impact of positron emission tomography/computed tomography in edge delineation of gross tumor volume for head and neck cancers.

Authors:  Hani Ashamalla; Adel Guirgius; Ewa Bieniek; Sameer Rafla; Alex Evola; Ganesh Goswami; Randall Oldroyd; Bahaa Mokhtar; Kapila Parikh
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-02-26       Impact factor: 7.038

7.  Comparison of PET-CT images with the histopathological picture of a resectable primary tumor for delineating GTV in nonsmall cell lung cancer.

Authors:  Shan Lin; Bo Han; Lijuan Yu; Dan Shan; Ruizhi Wang; Xiaoming Ning
Journal:  Nucl Med Commun       Date:  2011-06       Impact factor: 1.690

8.  Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.

Authors:  Jeffrey Bradley; Wade L Thorstad; Sasa Mutic; Tom R Miller; Farrokh Dehdashti; Barry A Siegel; Walter Bosch; Rudi J Bertrand
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-05-01       Impact factor: 7.038

Review 9.  Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.

Authors:  Andrea Billé; Ettore Pelosi; Andrea Skanjeti; Vincenzo Arena; Luca Errico; Piero Borasio; Maurizio Mancini; Francesco Ardissone
Journal:  Eur J Cardiothorac Surg       Date:  2009-05-22       Impact factor: 4.191

10.  FDG-PET/CT imaging for staging and target volume delineation in preoperative conformal radiotherapy of rectal cancer.

Authors:  Maria Chiara Bassi; Lucia Turri; Gianmauro Sacchetti; Gianfranco Loi; Barbara Cannillo; Pierdaniele La Mattina; Marco Brambilla; Eugenio Inglese; Marco Krengli
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-10-10       Impact factor: 7.038
View more
  2 in total

1.  Concordance of FDG PET/CT metabolic tumour volume versus DW-MRI functional tumour volume with T2-weighted anatomical tumour volume in cervical cancer.

Authors:  Alta Y T Lai; Jose A U Perucho; Xiaopei Xu; Edward S Hui; Elaine Y P Lee
Journal:  BMC Cancer       Date:  2017-12-06       Impact factor: 4.430

2.  CT scan and magnetic resonance diffusion-weighted imaging in the diagnosis and treatment of esophageal cancer.

Authors:  Lei Guo; Liulong Zhang; Jianshe Zhao
Journal:  Oncol Lett       Date:  2018-10-01       Impact factor: 2.967
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.